Your bridge to patients
in emerging markets

Unique solutions for
rare diseases

Promoting access to
life-saving medicines

Mastering orphan
drug pathways

Transforming
patient outcomes

Expanding
healthcare access

Commitment to
global health

We are a member of

Biomedica is a pharmaceutical company specialized in the
commercialization of rare disease products for patients in
underserved and emerging markets

Specializing in
rare diseases

We focus on rare disease offering extensive expertise in commercialization of orphan and ultra orphan products. Our mission is to promote healthcare equality by helping leading pharmaceutical companies to provide life-saving therapies to underserved markets.

Covering a wide geographical area

Our capabilities include helping you expand into over 30 emerging markets, creating value for your company, addressing unmet patient needs, and managing risks effectively to ensure a competitive and swift financial return.

Providing a full scope of services

Strategic guidance for market access pathways
Address registered and non-registered products
Ensure compliance with regulations
Provide expert solutions
View products as unique solutions
Offer personalized attention

Our team

Oleg Parosin
FOUNDER & CEO
Ludovit Jurecek
Head of Medical Affairs
Stan Filippin
Head of Business Development
Bozhidar Yordanov
CFO
Simeon Marinov
Head of Marketing and Innovation
Mikhail Smirnov
Business Development Director Russia
Albina Agametova
Head of Supply Chain
Souzana Vassileva
Head of HR
Eugenia Vinter
Head of Compliance
Simona Dzudza
Head of Pharmacovigilance
Krassimira Chemishanska
Regional Director South Europe and Black Sea
Buket Arbatli
Regional Director Turkey
Dmitriy Klimchuk
Regional Director Israel
Dimana Kadiyska
Director Regulatory Affairs
Anna Kurbatova
Head of Quality Assurance

Partner with Biomedica and commit to a healthier and more equitable world

Our testimonials

Prof. Oleg Kvlividze

MD, PhD

  • Georgian Foundation for Genetic and Rare Diseases (GeRaD) - CEO
  • EURORDIS, Full Member
  • RDI, Full Member
  • IRDIRC, FCC Member
Biomedica is the most innovative cutting-edge company providing the best practical solutions for the diagnosis and screening of orphan and ultra-ophthalmic patients in small countries where the problem of identifying and screening populations, especially children outside of big cities, is so actual. The medical department of Biomedica always offers the innovative, non-standard and highly effective solutions for the diagnosis and routing of patients, allowing us to identify even the only patient in the country and start the specific treatment. On behalf of the professional community, we are very grateful to the company for this contribution.

Halyna Kurylo

PhD, Pediatric Surgeon

  • Head of Surgery Department of Lviv City Clinical Children Hospital
As a lead paediatric surgeon and transplantologist in Ukraine, I’m truly grateful for Biomedica Group. They bring unique medicines to our patients who really need them. Their focus on special, rare treatments is something we don’t see often. They really understand each patient’s needs and find ways to help. Everyone in the medical field respects them. What’s amazing is how they find support for our kids. Biomedica isn’t just a business; they have a big heart. They always do more than expected for our children, and we’re lucky to work with them.

Dr. Dair Nurgaliev

MD, PhD

  • Head of Oncology & Bone Marrow Transplantation Department,  “University Medical Center” Corporate Fund, Astana, Kazahstan
In the ever-evolving landscape of pharmaceuticals, Biomedica shines brilliantly as a beacon of unwavering dedication and groundbreaking innovation. Over my extensive career as a professor, I've borne witness to the unique and often overlooked challenges many patients grapple with. Against this backdrop, Biomedica's personalized, boutique approach to delivering orphan and niche medicinal solutions is nothing short of revolutionary. Their relentless drive to cater to those with unaddressed medical needs, paired with their unparalleled expertise in engaging supportive payers, ensures that no patient, especially our precious children, remains in the shadows. Beyond their remarkable professional achievements, it's the heart and soul of Biomedica that truly resonates within our medical community. Their ethos is a poignant blend of sharp business acumen and profound empathy, making them not only a respected entity but also an inspiration. My heartfelt gratitude to Biomedica for lighting the path and setting the gold standard in patient care.

Prof. Oleg Kvlividze

MD, PhD

  • Georgian Foundation for Genetic and Rare Diseases (GeRaD) - CEO
  • EURORDIS, Full Member
  • RDI, Full Member
  • IRDIRC, FCC Member
Biomedica is the most innovative cutting-edge company providing the best practical solutions for the diagnosis and screening of orphan and ultra-ophthalmic patients in small countries where the problem of identifying and screening populations, especially children outside of big cities, is so actual. The medical department of Biomedica always offers the innovative, non-standard and highly effective solutions for the diagnosis and routing of patients, allowing us to identify even the only patient in the country and start the specific treatment. On behalf of the professional community, we are very grateful to the company for this contribution.

Halyna Kurylo

PhD, Pediatric Surgeon

  • Head of Surgery Department of Lviv City Clinical Children Hospital
As a lead paediatric surgeon and transplantologist in Ukraine, I’m truly grateful for Biomedica Group. They bring unique medicines to our patients who really need them. Their focus on special, rare treatments is something we don’t see often. They really understand each patient’s needs and find ways to help. Everyone in the medical field respects them. What’s amazing is how they find support for our kids. Biomedica isn’t just a business; they have a big heart. They always do more than expected for our children, and we’re lucky to work with them.

Dr. Dair Nurgaliev

MD, PhD

  • Head of Oncology & Bone Marrow Transplantation Department,  “University Medical Center” Corporate Fund, Astana, Kazahstan
In the ever-evolving landscape of pharmaceuticals, Biomedica shines brilliantly as a beacon of unwavering dedication and groundbreaking innovation. Over my extensive career as a professor, I've borne witness to the unique and often overlooked challenges many patients grapple with. Against this backdrop, Biomedica's personalized, boutique approach to delivering orphan and niche medicinal solutions is nothing short of revolutionary. Their relentless drive to cater to those with unaddressed medical needs, paired with their unparalleled expertise in engaging supportive payers, ensures that no patient, especially our precious children, remains in the shadows. Beyond their remarkable professional achievements, it's the heart and soul of Biomedica that truly resonates within our medical community. Their ethos is a poignant blend of sharp business acumen and profound empathy, making them not only a respected entity but also an inspiration. My heartfelt gratitude to Biomedica for lighting the path and setting the gold standard in patient care.

Looking for a strategic guidance?

Reach out to our team for market assessment specific to your product and understand the financial impact you can achieve by partnering with us.

We use cookies on our website to improve your experience and analyze traffic. By clicking "Accept" you consent to our use of cookies. See Privacy Policy
We use cookies on our website to improve your experience and analyze traffic. By clicking "Accept" you consent to our use of cookies. See Privacy Policy